Benefits at a glance.
Digestive comfort & bowel function
Helps maintain normal stool consistency, intestinal fluid balance and digestive comfort.
In a castor oil-induced diarrhoea model in Wistar rats, oral administration at 100 and 200 mg/kg significantly reduced wet fecal output. The 200 mg/kg dose produced 26.6% inhibition of diarrhoea (loperamide reference: 42.4%).
Support for microbial balance, barrier integrity, motility modulation and sodium/water absorption via probiotic-derived metabolites.
Gastric mucosal protection
Helps protect the stomach lining and supports gastric mucosal resilience.
In an ethanol-induced gastric ulcer model, Bacospore® significantly reduced ulcer index and gastric mucosal damage. Administration at 200 mg/kg produced ~80.4% inhibition of ulcer formation.
Increased mucus secretion, preserved epithelial integrity, reinforced mucosal defence and reductions in oxidative and inflammatory stress.
Healthy cholesterol metabolism
Supports normal cholesterol and bile acid metabolism.
In-vitro, Bacospore® produced concentration-dependent cholesterol reduction, from 0.34% at 31.25 µg/mL to 97.72% at 1,000 µg/mL, approaching the 99.41% reduction of the bile salt reference.
Cholesterol assimilation, co-precipitation with deconjugated bile salts and increased hepatic cholesterol utilization during bile acid synthesis.
Antioxidant support
Helps neutralize free radicals and supports cellular antioxidant defences.
In a comparative study of four Bacillus probiotics, B. coagulans MTCC 25308 recorded a DPPH IC₅₀ of 54.19 µg/mL, the strongest among strains tested (ascorbic acid reference: 21.97 µg/mL).
Association with probiotic-derived metabolites and enzymes including superoxide dismutase and catalase.
Collagen integrity
Helps protect collagen against enzymatic degradation.
Bacospore® exhibited concentration-dependent collagenase inhibition from 12.5 to 200 µg/mL. The highest concentration produced 85.40% collagenase inhibition.
Probiotic-derived peptides, exopolysaccharides and antioxidant metabolites may interact with collagenase or with matrix metalloproteinase-associated pathways.
Cellular fat metabolism
Supports normal adipocyte differentiation and cellular lipid metabolism.
In differentiated 3T3-L1 preadipocyte cells, B. coagulans MTCC 25308 produced moderate reduction in lipid accumulation and comparable inhibition of PPAR-γ expression while maintaining high cell viability.
Modulation of PPAR-γ expression may influence adipocyte differentiation and intracellular lipid storage. Positioned as cellular metabolic support.
Strain-specific preclinical evidence.
The benefit areas above rest on strain-specific animal, cellular and laboratory research on B. coagulans MTCC 25308, published across two peer-reviewed papers. Human research on other B. coagulans strains is presented separately as species-level background, so you always know which evidence supports which claim. These statements have not been evaluated by the FDA or EFSA. This product is not intended to diagnose, treat, cure or prevent any disease.